Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge.

Schwartz JA, Buonocore L, Suguitan AL Jr, Silaghi A, Kobasa D, Kobinger G, Feldmann H, Subbarao K, Rose JK.

J Virol. 2010 May;84 (9) :4611-8. Epub 2010 Feb 24. PMID: 20181720


Long-term vaccine protection from AIDS and clearance of viral DNA following SHIV89.6P challenge.

Schell J, Rose NF, Fazo N, Marx PA, Hunter M, Ramsburg E, Montefiori D, Earl P, Moss B, Rose JK.

Vaccine. 2009 Feb 11;27 (7) :979-86. Epub 2009 Jan 7. PMID: 19135115


Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection.

Chattopadhyay A, Park S, Delmas G, Suresh R, Senina S, Perlin DS, Rose JK.

Vaccine. 2008 Nov 25;26 (50) :6329-37. Epub 2008 Oct 1. PMID: 18832004


Hybrid alphavirus-rhabdovirus propagating replicon particles are versatile and potent vaccine vectors.

Rose NF, Publicover J, Chattopadhyay A, Rose JK.

Proc Natl Acad Sci U S A. 2008 Apr 15;105 (15) :5839-43. Epub 2008 Apr 7. PMID: 18391206


An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.

Rose NF, Marx PA, Luckay A, Nixon DF, Moretto WJ, Donahoe SM, Montefiori D, Roberts A, Buonocore L, Rose JK.

Cell. 2001 Sep 7;106 (5) :539-49. PMID: 11551502